首页> 外文期刊>Trials >Prospective controlled randomized trial on prevention of postoperative abdominal adhesions by Icodextrin 4% solution after laparotomic operation for small bowel obstruction caused by adherences [POPA study: Prevention of Postoperative Adhesions on behalf of the World Society of Emergency Surgery]
【24h】

Prospective controlled randomized trial on prevention of postoperative abdominal adhesions by Icodextrin 4% solution after laparotomic operation for small bowel obstruction caused by adherences [POPA study: Prevention of Postoperative Adhesions on behalf of the World Society of Emergency Surgery]

机译:腹腔镜手术后因粘连引起的小肠梗阻通过Icodextrin 4%溶液预防术后腹部粘连的前瞻性对照随机试验[POPA研究:代表世界紧急手术学会预防术后粘连

获取原文
       

摘要

Background Adhesive small intestine occlusion [ASIO] is an important cause of hospital admission placing a substantial burden on healthcare systems worldwide. Often times, ASIO is associated with significant morbidity and mortality. Icodextrin 4% solution [Adept, Shire Pharmaceuticals, UK] is a high-molecular-weight a-1,4 glucose polymer that is approved in Europe for use as an intra-operative lavage and a post-operative instillate to reduce the occurrence of post-surgery intra-abdominal adhesions. There are no randomized trials on the use of this solution to prevent adhesions after ASIO operation in current medical literature. The current clinical study evaluates the safety and effectiveness of Icodextrin 4% for decreasing the incidence, extent, and severity of adhesions in patients after abdominal surgery for ASIO. Design The study project is a prospective, randomized controlled investigation performed in the Department of Transplant, General and Emergency Surgery of St. Orsola-Malpighi University Hospital [Bologna, Italy]. The study is designed and conducted in compliance with the principles of Good Clinical Practice regulations. The study compares the results of Icodextrin 4% against a control group who does not receive anti-adhesion treatment. This randomized study uses a double-blind procedure to evaluate efficacy end points. In other words, designated third party individuals who are unaware of the treatment assigned to the patients to assess adhesion formation. Trial Registration Number ISRCTN22061989 Prospective controlled randomized trial on Prevention of Postoperative Abdominal Adhesions by Icodextrin 4% solution after laparotomic operation for small bowel obstruction caused by adherences [POPA study: Prevention of Postoperative Adhesions]
机译:背景技术小肠粘连[ASIO]是医院入院的重要原因,给全世界的医疗系统造成了沉重负担。通常,ASIO与明显的发病率和死亡率相关。 Icodextrin 4%溶液[Adept,Shire Pharmaceuticals,英国]是一种高分子量的a-1,4葡萄糖聚合物,在欧洲被批准用作手术中的灌洗液和手术后的滴注液,以减少发生手术后腹腔粘连。在目前的医学文献中,尚无关于使用这种溶液预防ASIO术后粘连的随机试验。当前的临床研究评估了4%的艾考曲宁用于降低ASIO腹部手术后患者粘连的发生率,程度和严重性的安全性和有效性。设计该研究项目是在圣奥索拉-马尔皮吉大学医院[意大利博洛尼亚]的移植,普通外科和急诊外科进行的一项前瞻性,随机对照研究。该研究是根据《临床实践规范》的原则设计和进行的。该研究将4%Icodextrin与未接受抗粘连治疗的对照组的结果进行了比较。这项随机研究采用双盲方法评估疗效终点​​。换句话说,将不知道治疗的指定第三方个人分配给患者以评估粘连形成。登记号为ISRCTN22061989的前瞻性对照随机对照试验,用于在腹腔镜手术后因粘连引起的小肠梗阻,用艾考特灵4%溶液预防术后腹部粘连[POPA研究:预防术后粘连]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号